Purpose Long-term randomized data assessing the effect of ablative therapies in patients
with oligometastases are lacking. The Stereotactic Ablative Radiotherapy for the …

Purpose: The oligometastatic state is a proposed entity between localized cancer and widely
metastatic disease, comprising an intermediate subset of metastatic cancer patients. Most …

PURPOSE The oligometastatic paradigm hypothesizes that patients with a limited number of
metastases may achieve long-term disease control, or even cure, if all sites of disease can …

Patients with metastatic solid tumors are usually treated with palliative intent. Systemic
therapy and palliative radiation are often used, with the goals of prolonging survival or …

Background A recent randomized phase II trial evaluated stereotactic ablative radiotherapy
(SABR) in a group of patients with a small burden of oligometastatic disease (mostly with 1 …

Background Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment
option for patients with oligometastatic disease. SABR delivers precise, high-dose …

Background Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment
option for patients with oligometastatic disease. SABR delivers precise, high-dose …

Background The oligometastatic paradigm suggests that some patients with a limited
number of metastases might be cured if all lesions are eradicated. Evidence from …

Purpose Oligometastatic disease has emerged as a potentially curable state in the spectrum
of cancer progression. Aggressive local therapy such as stereotactic ablative radiation …

Background Stereotactic radiotherapy (SRT) is a safe and locally effective treatment for
patients with inoperable oligometastases. The challenge remains identifying subsets of …